DuPont de Nemours (NYSE:DD) Stock Price Expected to Rise, Citigroup Analyst Says

DuPont de Nemours (NYSE:DDGet Free Report) had its target price lifted by equities researchers at Citigroup from $47.00 to $50.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the basic materials company’s stock. Citigroup’s target price suggests a potential upside of 16.12% from the company’s current price.

Several other brokerages have also recently weighed in on DD. KeyCorp raised their target price on shares of DuPont de Nemours from $45.00 to $51.00 and gave the stock an “overweight” rating in a report on Friday, January 9th. UBS Group raised their price objective on DuPont de Nemours from $46.00 to $49.00 and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Wells Fargo & Company decreased their target price on DuPont de Nemours from $100.00 to $50.00 and set an “overweight” rating on the stock in a report on Friday, November 7th. Deutsche Bank Aktiengesellschaft cut their target price on DuPont de Nemours from $90.00 to $46.00 and set a “buy” rating on the stock in a research report on Tuesday, November 25th. Finally, Royal Bank Of Canada increased their price target on DuPont de Nemours from $48.00 to $51.00 and gave the company an “outperform” rating in a research report on Wednesday. Ten investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $45.99.

View Our Latest Analysis on DuPont de Nemours

DuPont de Nemours Trading Up 1.8%

DuPont de Nemours stock traded up $0.78 during trading on Wednesday, reaching $43.06. The company had a trading volume of 1,407,671 shares, compared to its average volume of 4,914,949. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.63 and a current ratio of 2.00. The firm has a market capitalization of $18.04 billion, a price-to-earnings ratio of -23.41, a PEG ratio of 3.18 and a beta of 1.08. DuPont de Nemours has a 12-month low of $22.50 and a 12-month high of $44.17. The stock’s 50 day moving average price is $40.83 and its two-hundred day moving average price is $35.43.

DuPont de Nemours (NYSE:DDGet Free Report) last announced its quarterly earnings data on Thursday, November 6th. The basic materials company reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.05. DuPont de Nemours had a positive return on equity of 7.81% and a negative net margin of 6.17%.The firm had revenue of $3.07 billion for the quarter, compared to analysts’ expectations of $3.12 billion. During the same period last year, the business posted $1.18 earnings per share. The firm’s revenue for the quarter was down 2.9% on a year-over-year basis. DuPont de Nemours has set its Q4 2025 guidance at 0.430-0.430 EPS. As a group, equities analysts expect that DuPont de Nemours will post 4.38 earnings per share for the current fiscal year.

DuPont de Nemours announced that its Board of Directors has authorized a stock repurchase plan on Thursday, November 6th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the basic materials company to reacquire up to 12.2% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s leadership believes its shares are undervalued.

Insider Transactions at DuPont de Nemours

In related news, CEO Lori Koch sold 9,011 shares of the firm’s stock in a transaction that occurred on Friday, November 28th. The stock was sold at an average price of $39.46, for a total transaction of $355,574.06. Following the completion of the transaction, the chief executive officer owned 288,326 shares in the company, valued at $11,377,343.96. This trade represents a 3.03% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Erik T. Hoover sold 6,005 shares of the company’s stock in a transaction on Friday, November 28th. The shares were sold at an average price of $39.79, for a total value of $238,938.95. Following the completion of the sale, the senior vice president owned 112,101 shares in the company, valued at $4,460,498.79. This trade represents a 5.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.61% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Norges Bank acquired a new position in shares of DuPont de Nemours in the 2nd quarter valued at $313,306,000. Vanguard Group Inc. lifted its stake in DuPont de Nemours by 6.7% in the third quarter. Vanguard Group Inc. now owns 50,867,267 shares of the basic materials company’s stock valued at $3,962,560,000 after buying an additional 3,203,044 shares during the period. Invesco Ltd. boosted its holdings in DuPont de Nemours by 28.2% during the third quarter. Invesco Ltd. now owns 8,828,110 shares of the basic materials company’s stock worth $687,710,000 after buying an additional 1,942,589 shares during the last quarter. Mondrian Investment Partners LTD acquired a new position in shares of DuPont de Nemours during the 3rd quarter worth about $138,503,000. Finally, Ilex Capital Partners UK LLP increased its stake in shares of DuPont de Nemours by 175.8% in the 2nd quarter. Ilex Capital Partners UK LLP now owns 2,043,299 shares of the basic materials company’s stock valued at $140,150,000 after acquiring an additional 1,302,341 shares during the last quarter. 73.96% of the stock is owned by institutional investors.

DuPont de Nemours Company Profile

(Get Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

Further Reading

Analyst Recommendations for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.